Warning: The NCBI web site requires JavaScript to function. more...
Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA.
Live varicella virus vaccine was administered to 10 stable human immunodeficiency virus type 1 (HIV-1)-infected children. Subjects were monitored for adverse reactions, HIV-1 plasma levels, CD4 T cell counts and immune responses. The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on